AUS
NZ
UK
CA
USA
IND
Highlights
- New study provides detailed mapping of nasal microbiome diversity and colonization patterns.
- Photodisinfection offers a non-antibiotic approach to managing nasal pathogens.
- Research underscores limitations of conventional single-point screening methods.
Ondine Biomedical (LSE:OBI) advances light-activated nasal photodisinfection, offering an alternative method to manage pathogens while preserving beneficial microbiome balance.
Ondine Biomedical Inc. (LSE:OBI) operates within the life sciences sector, focusing on light-activated antimicrobial therapies. The company has recently highlighted findings from a newly published study in Nature Communications, which provides deeper biological insights into nasal decolonization strategies. The research, titled "Large-scale characterisation of the nasal microbiome redefines Staphylococcus aureus colonisation status," examined nasal microbial communities in detail, demonstrating the challenges associated with traditional antibiotic-based decolonization approaches.
Nasal Microbiome and Pathogen Colonization
The multicenter study analyzed nasal microbiomes from a large cohort of healthy adults, identifying multiple distinct microbial community types. One key observation is that Staphylococcus aureus colonization—a primary contributor to hospital-acquired infections—is often associated with a low-diversity microbial state that can suppress beneficial commensal bacteria. This finding provides important biological context for why conventional screening and antibiotic treatments may not fully address colonization risks.
The research also re-evaluated the concept of "intermittent carriers," showing that these individuals typically exhibit persistent colonization with fluctuating bacterial loads. This highlights that single-point-in-time culture swabs can fail to capture the full microbial dynamics, potentially overlooking periods when pathogen levels are low.
Photodisinfection as a Non-Chemical Approach
Photodisinfection, a core technology of Ondine Biomedical Inc. (LSE:OBI), uses light-activated antimicrobial methods to rapidly target a broad spectrum of pathogens. Unlike traditional antibiotics, this approach relies on an oxidative burst to remove harmful microorganisms without exerting selective pressure that can disrupt beneficial microbes. The method allows protective bacteria to repopulate the nasal passages naturally, potentially supporting overall microbial balance.
In healthcare environments, staff can act as temporary carriers of pathogens, making rapid, repeatable decolonization strategies valuable. Photodisinfection provides an adjunctive approach to conventional infection control practices, offering a physical means to reduce pathogen presence without relying on chemical agents.
Clinical and Global Application
Clinical evaluations presented at international infection control conferences have demonstrated notable reductions in hospital-acquired infections when universal photodisinfection protocols are implemented. Such findings indicate broader applicability of the technology across different healthcare settings, including intensive care units, oncology centers, dialysis facilities, and long-term care environments.
Ondine Biomedical Inc. (LSE:OBI) continues to deploy its nasal photodisinfection system in hospitals across multiple countries and is advancing clinical trials in the United States to support regulatory approval. The company’s focus on light-activated antimicrobial solutions reflects an ongoing commitment to alternative methods for pathogen management, including applications beyond nasal decolonization such as chronic sinus conditions and wound care.
Technological and Biological Significance
The recent study provides a scientific foundation for understanding the limitations of selective screening and antibiotic-based approaches. By mapping the nasal microbiome comprehensively, the research emphasizes the role of microbial community dynamics in pathogen persistence. Photodisinfection offers a targeted, repeatable, and non-chemical method to manage colonization, addressing challenges that traditional approaches cannot fully overcome.
